Is mRNA the Key to a Coronavirus Vaccine?

The race to find a coronavirus vaccine has brought a new approach to the forefront. The method involves harnessing the power of messenger RNA, and Sanofi (NASDAQ: SNY) is the latest company to give it a try, as part of a collaboration with Translate Bio (NASDAQ: TBIO). Other companies working on this technique include Moderna (NASDAQ: MRNA), BioNTech (NASDAQ: BNTX), and CureVac.

Now, the question is whether mRNA will be the winning ingredient. And if so, is there room for more than one player?

Image source: Getty Images.

Continue reading

Source Fool.com